SEVERE INFECTION IN ELDERLY PATIENTS TREATED WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF THE INTER-GROUPE FRANCOPHONE DU MYELOME (IFM) 2009 01 PROTOCOL

被引：0

作者：

Rodon, P. ^{[1
]}

Pegourie, B. ^{[2
]}

Garderet, L. ^{[3
]}

Casassus, P. ^{[4
]}

Decaux, O. ^{[5
]}

Roussel, M. ^{[6
]}

Chaleteix, C. ^{[7
]}

Royer, B. ^{[8
]}

Tiab, M. ^{[9
]}

Leleu, X. ^{[10
]}

Mathiot, C. ^{[11
]}

Hulin, C. ^{[12
]}

Moreau, P. ^{[13
]}

Lortholary, O. ^{[14
]}

Fermand, J. -P. ^{[15
]}

机构：

[1] Ctr Hosp, Hematol, Perigueux, France

[2] CHU Grenoble, Hematol, F-38043 Grenoble, France

[3] Hop St Antoine, AP HP, Hematol, F-75571 Paris, France

[4] Hop Avicenne, AP HP, Hematol, F-93009 Bobigny, France

[5] CHU, Med Interne, Rennes, France

[6] CHU, Hematol, Toulouse, France

[7] CHU, Hematol, Clermont Ferrand, France

[8] CHU, Hematol, Amiens, France

[9] Ctr Hosp, Hematol, La Roche Sur Yon, France

[10] CHU Lille, Hematol, F-59037 Lille, France

[11] Inst Curie, Hematol, Paris, France

[12] CHU, Hematol, Nancy, France

[13] CHU Nantes, Hematol, F-44035 Nantes 01, France

[14] Hop Necker Enfants Malad, AP HP, Malad Infect, Paris, France

[15] Hop St Louis, AP HP, Immunol Clin, Paris, France

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

E1250

引用

页码：501 / 502

页数：2

共 9 条

[1] BENDAMUSTINE, BORTEZOMIB AND DEXAMETHASONE (BVD) IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA : THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM) 2009-01 PROTOCOL
Rodon, P.
Hulin, C.
Pegourie, B.
Tiab, M.
Anglaret, B.
Benboubker, L.
Jardel, H.
Decaux, O.
Kolb, B.
Roussel, M.
Garderet, L.
Leleu, X.
Royer, B.
Banos, A.
Benramdane, R.
Cony-Makhoul, P.
Dib, M.
Fontan, J.
Stoppa, A.
Traulle, C.
Vilque, J.
Moreau, P.
Mathiot, C.
Avet-Loiseau, H.
HAEMATOLOGICA, 2012, 97 : 342 - 342
[2] Bendamustine, bortezomib, and dexamethasone (BVD) in elderly patients with relapsed/refractory multiple myeloma (RRMM): The Intergroupe Francophone du Myelome (IFM) 2009-01 protocol.
Rodon, Philippe
Hulin, Cyrille
Pegourie, Brigitte
Tiab, Mourad
Anglaret, Bruno
Benboubker, Lotfi
Jardel, Henry
Decaux, Olivier
Kolb, Brigitte
Roussel, Murielle
Garderet, Laurent
Leleu, Xavier
Fitoussi, Olivier
Chaleteix, Carine
Casassus, Philippe
Lenain, Pascal
Moreau, Philippe
Petillon, Marie-Odile
Mathiot, Claire
Avet-Loiseau, Herve
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[3] Bendamustine, Bortezomib and Dexamethasone (BVD) In Elderly Patients With Multiple Myeloma In First Relapse: Final Analysis Of The Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial
Rodon, Philippe
Hulin, Cyrille
Pegourie, Brigitte
Tiab, Mourad
Anglaret, Bruno
Benboubker, Lotfi
Jardel, Henry
Decaux, Olivier
Kolb, Brigitte
Roussel, Murielle
Garderet, Laurent
Leleu, Xavier
Fitoussi, Olivier
Chaleteix, Carine
Casassus, Philippe
Lenain, Pascal
Royer, Bruno
Banos, Anne
Benramdane, Riad
Cony-Makhoul, Pascale
Dib, Mamoun
Fontan, Jean
Stoppa, Anne-Marie
Traulle, Catherine
Vilque, Jean-Pierre
Petillon, Marie-Odile
Mathiot, Claire
Avet-Loiseau, Herve
Moreau, Philippe
BLOOD, 2013, 122 (21)
[4] Bendamustine, Bortezomib and Dexamethasone (BVD) in Elderly Patients with Multiple Myeloma in First Relapse: Updated Results of the Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial
Rodon, Philippe
Hulin, Cyrille
Pegourie, Brigitte
Tiab, Mourad
Anglaret, Bruno
Benboubker, Lotfi
Jardel, Henry
Decaux, Olivier
Kolb, Brigitte
Roussel, Murielle
Garderet, Laurent
Leleu, Xavier
Fitoussi, Olivier
Chaleteix, Carine
Casassus, Philippe
Lenain, Pascal
Moreau, Philippe
Petillon, Marie Odile
Mathiot, Claire
Avet-Loiseau, Herve
BLOOD, 2012, 120 (21)
[5] Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial
Rodon, Philippe
Hulin, Cyrille
Pegourie, Brigitte
Tiab, Mourad
Anglaret, Bruno
Benboubker, Lotfi
Jardel, Henry
Decaux, Olivier
Kolb, Brigitte
Roussel, Murielle
Garderet, Laurent
Leleu, Xavier
Fitoussi, Olivier
Chaleteix, Carine
Casassus, Philippe
Lenain, Pascal
Royer, Bruno
Banos, Anne
Benramdane, Riad
Cony-Makhoul, Pascale
Dib, Mamoun
Fontan, Jean
Stoppa, Anne-Marie
Traulle, Catherine
Vilque, Jean-Pierre
Petillon, Marie-Odile
Mathiot, Claire
Dejoie, Thomas
Avet-Loiseau, Herve
Moreau, Philippe
HAEMATOLOGICA, 2015, 100 (02) : E56 - E59
[6] Double autologous transplantation improves survival of multiple myeloma patients: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome" (IFM 94).
Attal, M
Harousseau, JL
Facon, T
Guilhot, F
Doyen, C
Fuzibet, JG
Monconduit, M
Hullen, C
Caillot, D
Bouabdallah, R
Voillat, L
Sotto, JJ
Grosbois, B
Bataille, R
BLOOD, 2002, 100 (11) : 5A - 6A
[7] Daratumumab Plus Ixazomib, Lenalidomide, and Dexamethasone As Extended Induction and Consolidation Followed By Lenalidomide Maintenance in Standard-Risk Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (IFM 2018-01): A Phase II Study of the Intergroupe Francophone Du Myelome (IFM)
Perrot, Aurore
Lauwers-Cances, Valerie
Touzeau, Cyrille
Decaux, Olivier
Hulin, Cyrille
Macro, Magaret
Stoppa, Anne-Marie
Chretien, Marie Lorraine
Karlin, Lionel
Mariette, Clara
Jacquet, Caroline
Roussel, Murielle
Guillemot, Coralie
Devlamynck, Laure
Avet-Loiseau, Herve
Moreau, Philippe
Attal, Michel
BLOOD, 2021, 138
[8] A multicenter prospective randomized study testing non-inferiority of thalidomide 100 mg/day as compared with 400 mg/day in patients with refractory/relapsed multiple myeloma: Results of the final analysis of the IFM 01-02 study.
Yakoub-Agha, I.
Doyen, C.
Hulin, C.
Marit, G.
Voillat, L.
Grosbois, B.
Harousseau, J.
Duguet, C.
Zerbib, R.
Facon, T.
Mary, J.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 427S - 427S
[9] A multicenter prospective randomized study testing non-inferiority of thalidomide 100 mg/day as compared with 400 mg/day in patients with refractory/relapsed multiple myeloma: First results of the final analysis of the IFM 01-02 study.
Yakoub-Agha, I
Hulin, C
Doyen, C
Benboubker, L
Voillat, L
Bouabdallah, K
Guillerm, G
Moreau, R
Maloisel, F
Stoppa, AM
Pegourie, B
Rodon, P
Dib, M
Casassus, P
Slama, B
Voog, E
Jardel, H
Collet, P
Wettervald, M
Peny, AM
Mineur, P
Duguet, C
Zerbib, R
Facon, T
Mary, JY
BLOOD, 2005, 106 (11) : 110A - 110A

← 1 →